Related Experiment Video
Updated: Apr 13, 2026

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
23.3K
Deep brain stimulation for Parkinson's disease: recent trends and future direction
Chikashi Fukaya1, Takamitsu Yamamoto
1Division of Applied System Neuroscience, Department of Neurological Surgery, Nihon University School of Medicine.
Neurologia Medico-Chirurgica
|May 1, 2015
Summary
Deep brain stimulation (DBS) for Parkinson's disease (PD) needs better understanding of its effects on neural circuits. This review covers current DBS practices, target selection, and challenges for improved patient outcomes.
Area of Science:
- Neurosurgery
- Neurology
- Medical Engineering
Background:
- Deep brain stimulation (DBS) is widely used for Parkinson's disease (PD), with over 120,000 global procedures.
- Fundamental understanding of DBS effects on pathological neural circuitry, particularly cortico-striato-thalamo-cortical (CSTC) loops, remains limited.
- DBS can impact motor, cognitive, and affective functions in PD patients.
Purpose of the Study:
- To review the current state of DBS for PD, focusing on subthalamic nucleus (STN) and globus pallidus interna (GPi) targets.
- To discuss indications, practical effects, complications, and adverse events associated with DBS in PD.
- To explore target selection (GPi vs. STN), DBS effects on non-motor symptoms, and unresolved issues.
Main Methods:
- Review of existing literature on DBS for Parkinson's disease.
- Analysis of studies focusing on STN-DBS and GPi-DBS.
- Discussion of surgical complications and stimulation-induced adverse events.
Main Results:
- Subthalamic nucleus (STN) and globus pallidus interna (GPi) are primary DBS targets for PD.
- Ventralis intermedius (Vim)-DBS is effective for tremor but not akinesia or rigidity.
- DBS influences both motor and non-motor symptoms, with ongoing research into optimal targets and parameters.
Conclusions:
- Further research is needed to fully understand DBS mechanisms in PD.
- Optimal surgical timing, management of unresponsive symptoms (e.g., axial symptoms), and postoperative programming require resolution.
- Continued investigation into target selection and non-motor symptom effects will refine DBS therapy for PD.

